The current study reveals a novel therapeutic mechanism by which BM-MSC-derived migrasomes alleviate poststroke immunosuppression through targeted delivery of the Pin1 protein to TEC, thereby reversing stroke-induced thymic atrophy and restoring peripheral immune homeostasis. This evidence concerns the gene PIN1 and Stroke.